Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Launched by POWER LIFE SCIENCES INC. · Jun 22, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring the experiences of patients who are considering or participating in immunotherapy clinical trials for cancer. The researchers want to understand what factors help or hinder patients from joining and completing these studies. By collecting and analyzing information from different groups of patients, they hope to find ways to improve the overall experience for future immunotherapy patients.

To be eligible for this trial, participants must be at least 18 years old, have been diagnosed with cancer, and plan to join an interventional clinical trial using immunotherapy. However, individuals with a high level of disability (an ECOG score of 4 or higher) or those unable to provide consistent reports as needed for the study will not be able to participate. Once involved, participants can expect to share their experiences and insights, which will help shape the future of immunotherapy trials. This study is not yet recruiting participants, but it aims to create a better understanding of how to support patients in these important clinical trials.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient has self-identified as planning to participate in an interventional clinical trial using immunotherapy
• • Patient has been diagnosed with a type of cancer
• • Patient is a minimum of 18 years or older
• Exclusion Criteria:
• • Patient has an ECOG score of 4 or higher
• • Patient is not able to provide consistent digital reporting as per study requirements
• • Patient does not complete Informed Consent Form